ARDENT HEALTH INC
ARDTNYSE🏆 #2205 by market capEarnings Nov 10US Equity
$10.58▲ $0.11 (+1.05%)
🌙 After hours$10.58▲ 0.00%Regular close · extended-hours price shownTrack ARDT
Get earnings, price moves & breaking news on Telegram
24h▲ 1.1%
7d▼ 0.5%
14d▼ 1.3%
30d▼ 2.2%
ytd▲ 20.0%
1y▼ 20.2%
🏦Market Cap
$1.52B
Small Cap
📈Revenue Growth (YoY)
+6.0%
Slowing
📊Gross Margin
30.0%
Moderate
💵FCF Margin
4.7%
Moderate
⚖️P/S Ratio
0.2x
Cheap
Otter Score
64
Fair
ARDENT HEALTH INC
ARDTAnalyst Ratings
Price
$10.58
Total
12
Raised
0
Lowered
2
Avg PT
$12.67
H / L
$14 / $11
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Leerink Partners | Reiterated | Outperform | 2026-09-18 | $16.00 | +51.20% |
RBC Capital | Reiterated | Outperform | 2026-08-10 | $13.00 | +22.90% |
Truist Securities | Reiterated | Buy | 2026-08-06 | — | — |
Guggenheim | Reiterated | Buy | 2026-08-06 | $14.00 | +32.30% |
UBS | Reiterated | Buy | 2026-05-07 | $14.00 | +32.30% |
JP Morgan | Reiterated | Neutral | 2026-01-20 | — | — |
Mizuho | Reiterated | Outperform | 2025-12-18 | — | — |
Keybanc | Downgraded | Overweight → Sector Weight | 2025-11-17 | $24.00 | +126.80% |
Stephens & Co. | Reiterated | Overweight | 2025-11-14 | — | — |
Morgan Stanley | Downgraded | Overweight → Equal Weight | 2025-11-14 | $12.00 | +13.40% |
B of A Securities | Reiterated | Underperform | 2025-11-13 | — | — |
Loop Capital | Reiterated | Buy | 2024-08-16 | — | — |
Institution
Leerink Partners
Reiterated · Outperform · 2026-09-18
$16.00
+51.20%
RBC Capital
Reiterated · Outperform · 2026-08-10
$13.00
+22.90%
Truist Securities
Reiterated · Buy · 2026-08-06
—
—
Guggenheim
Reiterated · Buy · 2026-08-06
$14.00
+32.30%
UBS
Reiterated · Buy · 2026-05-07
$14.00
+32.30%
JP Morgan
Reiterated · Neutral · 2026-01-20
—
—
Mizuho
Reiterated · Outperform · 2025-12-18
—
—
Keybanc
Downgraded · Overweight → Sector Weight · 2025-11-17
$24.00
+126.80%
Stephens & Co.
Reiterated · Overweight · 2025-11-14
—
—
Morgan Stanley
Downgraded · Overweight → Equal Weight · 2025-11-14
$12.00
+13.40%
B of A Securities
Reiterated · Underperform · 2025-11-13
—
—
Loop Capital
Reiterated · Buy · 2024-08-16
—
—
One row per institution · price target from the firm's latest published target